<html>
  <head>
    <title>suwn8-k.htm</title>
<!-- Licensed to: China Direct, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.3 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div>&#160;</div>
    <div>
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
      <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
    </div>
    <div>&#160;</div>
    <div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED
STATES</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES
AND EXCHANGE COMMISSION</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington,
D.C. 20549</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">______________</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FORM
8-K</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">______________</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CURRENT
REPORT</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PURSUANT
TO SECTION 13 OR 15(D) OF THE</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES
EXCHANGE ACT OF 1934</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DATE OF
REPORT (DATE OF EARLIEST EVENT REPORTED): &#160;&#160;December 17,
2008</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SUNWIN
INTERNATIONAL NEUTRACEUTICALS, INC.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(EXACT
NAME OF REGISTRANT AS SPECIFIED IN CHARTER)</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="top" width="34%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nevada</font></div>
              </td>
              <td valign="top" width="25%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">033-10456</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td valign="top" width="31%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56-2416925</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="34%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(STATE
      OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)</font></div>
              </td>
              <td valign="top" width="25%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(COMMISSION
      FILE NO.)</font></div>
              </td>
              <td valign="top" width="31%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(IRS
      EMPLOYEE IDENTIFICATION NO.)</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6
Youpeng Road, Qufu, Shandong, China 273100</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ADDRESS
OF PRINCIPAL EXECUTIVE OFFICES)</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(86)
537-4424999)</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ISSUER
TELEPHONE NUMBER)</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(FORMER
NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions ( see&#160;&#160;General Instruction A.2. below):</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="part_1_2_1" /><a name="item_1_26_1"><br></a></div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="6%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Item
      1.01</font></div>
              </td>
              <td align="left" valign="top" width="94%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Entry
      into a Material Definitive
Agreement.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top">
              <td style="WIDTH: 59.4pt">
                <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td>
                <div align="left">&#160;</div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
February 5, 2009, Sunwin International Neutraceuticals, Inc. (the &#8220;Company&#8221;)
entered into a <a name="part_1_2_2" /><a name="item_1_36_1">Securities Purchase
Agreement (the &#8220;Securities Purchase Agreement&#8221;) with Wild Flavors, Inc. (&#8220;Wild
Flavors&#8221;) to purchase 20,000,000 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common
stock, $0.001 par value per share (the &#8220;Common Stock&#8221;) at a price of $.15 per
share (the &#8220;Wild Flavors Stock&#8221;) together with&#160;five year warrants to
purchase 26,666,666 shares of common stock with an exercise price of $0.35 per
share (the &#8220;Warrants&#8220;). Upon completion of the sale of the Shares and other
transactions agreed to in connection with the Securities Purchase Agreement,
Wild Flavorss will own approximately 15.7% of the issued and outstanding Common
Stock of the Company.</a></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to the terms of the Securities Purchase Agreement, the Company agreed to convert
its wholly owned subsidiary, Sunwin Stevia International Corp., a Florida
corporation (&#8220;Sunwin USA&#8221;), into a Delaware limited liability
company.&#160;&#160;In exchange for its contribution of Sunwin USA&#8217;s current
capital, the Company will receive 5,500 membership units in Sunwin USA, a 55%
interest after giving effect to the issuance of membership units to Wild
Flavors.&#160;&#160;In addition, the Company agreed to issue to Wild Flavors
4,500 membership units (a 45% interest) in Sunwin USA in exchange for Wild
Flavors&#8217; agreement to provide sales, marketing, logistics and supply chain
management, product development and regulatory services to Sunwin USA over a
period of two years beginning on February 5, 2009 (the &#8220;Services&#8221;). The Company
and Wild Flavors agreed that the value of the Services are $1,000,000. In
addition, Wild Flavors has agreed to act as the sole manager of Sunwin USA and
will be responsible for all of its business and affairs as provided for in the
proposed form of the Operating Agreement to be entered into between Wild Flavors
and the Company (the "Operating Agreement"). In addition, Wild Flavors has the
right of first refusal to purchase additional membership units in Sunwin USA at
$222.22 per unit to provide any additional capital required by Sunwin USA as
jointly determined by the Company and Wild Flavors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under the
terms of the Securities Purchase Agreement, Wild Flavors has the option to
exchange its 45% interest in Sunwin USA into 6,666,666 shares of the Company&#8217;s
Common Stock at any time until December 31, 2010 (the &#8220;Exchange
Option&#8221;).&#160;&#160;Wild Flavors is also entitled to a bonus option which would
entitle it to receive the greater of 6% of the issued and outstanding membership
units of Sunwin USA or the number of membership units of Sunwin USA necessary to
get Wild&#8217;s ownership interest to 51% if (i) Sunwin USA achieves cumulative
pre-tax profits of $3,000,000 on or before December 31, 2011 computed in
accordance with Generally Accepted Accounting Principles in the United States
(&#8220;GAAP&#8221;) exclusive of the cost of product liability insurance and (ii) Wild
Flavors has not exercised its Exchange Option (the &#8220;Bonus Option&#8221;). Upon
exercise of the Bonus Option, Wild Flavors is obligated to pay Sunwin USA an
aggregate exercise price of $1,000.00.&#160;&#160;The Bonus Option expires upon
the earlier of the date when one of the above conditions can no longer be
satisfied and July 1, 2012.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shandong
Shengwang Pharmaceutical Co., Ltd (&#8220;Shandong Shengwang&#8221;), a China limited
liability company controlled by the Company&#8217;s Chairman of the Board, Laiwang
Zhang, has agreed to waive fees it charges the Company to provide consulting
services to certain of its subsidiaries, including maintaining infrastructure
and covering utility expenses of those entities for the calendar year 2009. In
addition, Shandong Shengwang has agreed that starting January 2010, the maximum
consulting fee that will be charged to the Company by Shandong Shengwang will be
approximately $175,508 (RMB1,200,000) per year.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
February 5, 2009, the Company entered into a Distributorship Agreement with its
subsidiary, Sunwin Stevia International Corp. (&#8220;Sunwin USA&#8221;) and Wild Flavors
for the worldwide distribution of the Company&#8217;s Stevia sweetener
products.&#160;&#160;The Distributorship Agreement is for an initial term of 60
months with automatic renewal terms of 12 successive 36 month renewal
periods.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As part
of the Securities Purchase Agreement, the Company, Wild Flavors and certain
shareholders of the Company owning approximately 34.12% of the Company&#8217;s common
stock (the &#8220;Sunwin Shareholders&#8221;) entered into a Stockholders Agreement dated
February 5, 2009 (the &#8220;Stockholders Agreement&#8221;).&#160;&#160;The Stockholders
Agreement provides that so long as Wild Flavors owns at least 4,000,000 shares
of the Common Stock, the parties will vote or cause their shares of the Common
Stock to be voted to elect two members of the Company&#8217;s board of directors
designated by Wild Flavors and three members designated by the Sunwin
Shareholders.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
descriptions of the terms and conditions of the Securities Purchase Agreement,
Operating Agreement, Distributorship Agreement and Stockholders Agreement set
forth herein do not purport to be complete and are qualified in their entirety
by reference to the full text of such documents attached hereto as exhibits and
incorporated herein by reference.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="6%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Item
      3.02</font></div>
              </td>
              <td align="left" valign="top" width="94%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Recent
      Sales of Unregistered Securities.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to the Securities Purchase Agreement, Wild Flavors purchased 20,000,000 shares
(the &#8220;Shares&#8221;) of the Company&#8217;s Common Stock at a price of $.15 per share and
five year warrants to purchase 26,666,666 shares of the Common Stock with an
exercise price of $0.35 per share (the &#8220;Warrants&#8220;).&#160;&#160;Upon completion
of the sale of the Shares and other transactions agreed to in connection with
the Securities Purchase Agreement, Wild Flavors will own approximately 15.7% of
the issued and outstanding Common Stock of the Company. In addition, Sunwin USA
agreed to agreed to issue to Wild Flavors 4,500 membership units (the &#8220;Units&#8221;)
(a 45% interest) in Sunwin USA in exchange for Wild Flavors&#8217; agreement to
provide the Services to Sunwin USA over a period of two years begining on
February 5, 2009.&#160;&#160;The sale of the Shares, Warrants and Units is
hereinafter collectively referred to as the Wild Flavors
Offering.</font></div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 1
-</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Wild
Flavors Offering was made in reliance on the exemption from registration
provided by Section 4(2) of the Securities Act of 1933. The sale of the Shares,
Warrants and Units (the &#8220;Sunwin Securities&#8221;) to Wild Flavors, when completed,
will qualify for exemption under Section 4(2) of the Securities Act of 1933
since the sale by the Company and Sunwin USA did not involve a public offering.
Wild Flavors agreed not to resell the Sunwin Securities for a period of two
years after the February 5, 2009 closing date of the Wild Flavors
Offering.&#160;&#160;In addition, Wild Flavors is a sophisticated investor and
had access to information normally provided in a prospectus regarding the
Company. The Wild Flavors Offering was not a &#8220;public offering&#8221; as defined in
Section 4(2) due to the insubstantial number of persons involved in the deal,
size of the offering, manner of the offering and number of shares offered. The
Company did not undertake an offering in which it sold a high number of shares
to a high number of investors. In addition, Wild Flavors had the necessary
investment intent as required by Section 4(2) since Wild Flavors agreed to allow
the Company to include a restrictive legend on any of the Sunwin Securities
acquired stating that such securities are restricted pursuant to Rule 144 of the
1933 Securities Act. These restrictions ensure that these securities would not
be immediately redistributed into the market and therefore not be part of a
&#8220;public offering.&#8221; Based on an analysis of the above factors, the Company will
have met the requirements to qualify for exemption under Section 4(2) of the
Securities Act of 1933 for the Wild Flavors Offering.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Company paid fees in connection with the Securities Purchase Agreement of
$100,000 in cash and 1,000,000 shares of its Common Stock. In addition, the
Company paid legal fees to its counsel associated with the Securities Purchase
Agreement. After payment of these fees and costs associated with the Wild
Flavors Offering, the Company received net proceeds of approximately $2,885,000.
The net proceeds of this offering will be used for expansion of the Company&#8217;s
Stevia production facilities in China and general corporate
purposes.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Securities Purchase Agreement gives Wild Flavors the right to receive notice of
and participate in the Company&#8217;s proposed sale of its securities except for (i)
transactions involving strategic mergers, acquisitions; (ii) license and
partnering arrangements so long as such issuances are not for the purpose of
raising capital and which holders of such securities are not at any time granted
registration rights and issuances; (iii) grants pursuant to stock option plans
and employee stock purchase plans; and (iv) issuances as a result of the
exercise of existing warrants to purchase the Company&#8217;s common
stock.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
addition, the&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Securities
Purchase Agreement also gives Wild Flavors, among other rights,&#160;a right of
first refusal with respect to subsequent offers, if any, by the Company for the
sale of its securities or debt obligations up until February 5, 2011. The right
of first refusal does not apply with respect to certain limited exceptions,
including strategic license agreements, mergers and similar acquisitions and
certain option programs.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
descriptions of the terms and conditions of the Warrants set forth herein do not
purport to be complete and are qualified in their entirety by reference to the
full text of such document attached hereto as exhibits and incorporated herein
by reference.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="6%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Item
      7.01&#160;&#160;</font></div>
              </td>
              <td align="left" valign="top" width="94%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Regulation
      FD Disclosure</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
February 11, 2009, Wild Flavors, Inc. and the Company issued a press release
announcing the business relationship contemplated in the Securities Purchase
Agreement and the agreements set forth in such agreement.&#160;&#160;A copy of
the press release is attached hereto as Exhibit 99.1 and incorporated by
reference herein.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
information in this item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.1, shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or
otherwise subject to the liability of that section, and shall not be
incorporated by reference into any registration statement or other document
filed under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such
filing.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 2
-</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="10%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Item
      9.01</font></div>
              </td>
              <td align="left" valign="top" width="68%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financial
      Statements and Exhibits.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
Exhibits</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <div align="left">
          <div align="left">
            <div align="left">
              <div align="left">
                <table cellpadding="3" cellspacing="0" width="100%">
                    <tr>
                      <td align="left" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exhibit
      No.</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td align="left" valign="bottom" width="93%" style="BORDER-BOTTOM: black 2px solid">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Description</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" valign="middle" width="6%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.1</font></div>
                      </td>
                      <td align="left" valign="middle" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td align="left" valign="middle" width="93%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common
      Stock Purchase Warrant between Sunwin International Neutraceuticals, Inc.
      and Wild Flavors, Inc. dated February 5, 2009.</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" valign="middle" width="6%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.2</font></div>
                      </td>
                      <td valign="middle" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td align="left" valign="middle" width="93%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stockholders
      Agreement dated February 5, 2009 Sunwin International Neutraceuticals,
      Inc., Laiwang Zhang, Dongdong Lin, Xingyuan Li, Junzhen Zhang, Xiangsheng
      Kong, Weidong Chai, Laiwang Zhang, Fanjun Wu and Wild Flavors,
      Inc.</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" valign="middle" width="6%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.1</font></div>
                      </td>
                      <td align="left" valign="middle" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td align="left" valign="middle" width="93%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities
      Purchase Agreement between Sunwin International Neutraceuticals, Inc. and
      Wild Flavors, Inc. dated February 5, 2009.</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" valign="middle" width="6%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.2</font></div>
                      </td>
                      <td align="left" valign="middle" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td align="left" valign="middle" width="93%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form
      of Operating Agreement between Sunwin International Neutraceuticals, Inc.
      and Wild Flavors, Inc.</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" valign="middle" width="6%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.3</font></div>
                      </td>
                      <td valign="middle" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td align="left" valign="middle" width="93%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Distributorship
      Agreement dated February 5, 2009 among Sunwin International
      Neutraceuticals, Inc., Sunwin Stevia International Corp. and Wild Flavors,
      Inc.*</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" width="6%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">99.1</font></div>
                      </td>
                      <td valign="middle" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td align="left" valign="middle" width="93%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Joint
      Press Release of Wild Flavors, Inc. and Sunwin International
      Neutraceuticals, Inc. dated February 11, 2009 (furnished
      herewith).</font></div>
                        <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
                      </td>
                    </tr>
                </table>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*Portions
of this agreement have been omitted and marked with a <font style="DISPLAY: inline; FONT-WEIGHT: bold">[_]</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>and separately filed
with the Securities and Exchange Commission with a request for confidential
treatment.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="part_1_2_4"><br></a></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="46%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" colspan="2" valign="top" width="54%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sunwin
      International Neutraceuticals, Inc.</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" width="46%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="46%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date:
      February 11, 2009</font></div>
              </td>
              <td align="left" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
              </td>
              <td align="left" valign="top" width="50%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;/s/
      Dongdong Lin&#160;</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" width="46%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="50%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dongdong
      Lin, Chief Executive Officer</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" width="46%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 3
-</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br></div>
  </body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "suwn8-k.htm", "description": "CURRENT REPORT ON FORM 8-K", "secsgml_size_bytes": 45544}]
{"company-data": {"conformed-name": "SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.", "cik": "0000806592", "assigned-sic": "2834", "irs-number": "562416925", "fiscal-year-end": "0430"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "033-10456", "film-number": "09587604"}, "business-address": {"street1": "6 YOUPENG ROAD", "city": "QUFU, SHANDONG", "state": "F4", "zip": "273100", "phone": "(86) 537-4424999"}, "mail-address": {"street1": "6 YOUPENG ROAD", "city": "QUFU, SHANDONG", "state": "F4", "zip": "273100"}, "former-company": [{"former-conformed-name": "NETWORK USA INC", "date-changed": "20000731"}, {"former-conformed-name": "PACIFIC RESOURCES INC", "date-changed": "19870605"}]}
suwn8-k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM
8-K
______________
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
DATE OF
REPORT (DATE OF EARLIEST EVENT REPORTED):   December 17,
2008
SUNWIN
INTERNATIONAL NEUTRACEUTICALS, INC.
(EXACT
NAME OF REGISTRANT AS SPECIFIED IN CHARTER)
Nevada
033-10456
56-2416925
(STATE
      OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)
(COMMISSION
      FILE NO.)
(IRS
      EMPLOYEE IDENTIFICATION NO.)
6
Youpeng Road, Qufu, Shandong, China 273100
(ADDRESS
OF PRINCIPAL EXECUTIVE OFFICES)
(86)
537-4424999)
(ISSUER
TELEPHONE NUMBER)
(FORMER
NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions ( see  General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
      1.01
Entry
      into a Material Definitive
Agreement.
On
February 5, 2009, Sunwin International Neutraceuticals, Inc. (the "Company")
entered into a
Securities Purchase
Agreement (the "Securities Purchase Agreement") with Wild Flavors, Inc. ("Wild
Flavors") to purchase 20,000,000 shares (the "Shares") of the Company's common
stock, $0.001 par value per share (the "Common Stock") at a price of $.15 per
share (the "Wild Flavors Stock") together with five year warrants to
purchase 26,666,666 shares of common stock with an exercise price of $0.35 per
share (the "Warrants"). Upon completion of the sale of the Shares and other
transactions agreed to in connection with the Securities Purchase Agreement,
Wild Flavorss will own approximately 15.7% of the issued and outstanding Common
Stock of the Company.
Pursuant
to the terms of the Securities Purchase Agreement, the Company agreed to convert
its wholly owned subsidiary, Sunwin Stevia International Corp., a Florida
corporation ("Sunwin USA"), into a Delaware limited liability
company.  In exchange for its contribution of Sunwin USA's current
capital, the Company will receive 5,500 membership units in Sunwin USA, a 55%
interest after giving effect to the issuance of membership units to Wild
Flavors.  In addition, the Company agreed to issue to Wild Flavors
4,500 membership units (a 45% interest) in Sunwin USA in exchange for Wild
Flavors' agreement to provide sales, marketing, logistics and supply chain
management, product development and regulatory services to Sunwin USA over a
period of two years beginning on February 5, 2009 (the "Services"). The Company
and Wild Flavors agreed that the value of the Services are $1,000,000. In
addition, Wild Flavors has agreed to act as the sole manager of Sunwin USA and
will be responsible for all of its business and affairs as provided for in the
proposed form of the Operating Agreement to be entered into between Wild Flavors
and the Company (the "Operating Agreement"). In addition, Wild Flavors has the
right of first refusal to purchase additional membership units in Sunwin USA at
$222.22 per unit to provide any additional capital required by Sunwin USA as
jointly determined by the Company and Wild Flavors.
Under the
terms of the Securities Purchase Agreement, Wild Flavors has the option to
exchange its 45% interest in Sunwin USA into 6,666,666 shares of the Company's
Common Stock at any time until December 31, 2010 (the "Exchange
Option").  Wild Flavors is also entitled to a bonus option which would
entitle it to receive the greater of 6% of the issued and outstanding membership
units of Sunwin USA or the number of membership units of Sunwin USA necessary to
get Wild's ownership interest to 51% if (i) Sunwin USA achieves cumulative
pre-tax profits of $3,000,000 on or before December 31, 2011 computed in
accordance with Generally Accepted Accounting Principles in the United States
("GAAP") exclusive of the cost of product liability insurance and (ii) Wild
Flavors has not exercised its Exchange Option (the "Bonus Option"). Upon
exercise of the Bonus Option, Wild Flavors is obligated to pay Sunwin USA an
aggregate exercise price of $1,000.00.  The Bonus Option expires upon
the earlier of the date when one of the above conditions can no longer be
satisfied and July 1, 2012.
Shandong
Shengwang Pharmaceutical Co., Ltd ("Shandong Shengwang"), a China limited
liability company controlled by the Company's Chairman of the Board, Laiwang
Zhang, has agreed to waive fees it charges the Company to provide consulting
services to certain of its subsidiaries, including maintaining infrastructure
and covering utility expenses of those entities for the calendar year 2009. In
addition, Shandong Shengwang has agreed that starting January 2010, the maximum
consulting fee that will be charged to the Company by Shandong Shengwang will be
approximately $175,508 (RMB1,200,000) per year.
On
February 5, 2009, the Company entered into a Distributorship Agreement with its
subsidiary, Sunwin Stevia International Corp. ("Sunwin USA") and Wild Flavors
for the worldwide distribution of the Company's Stevia sweetener
products.  The Distributorship Agreement is for an initial term of 60
months with automatic renewal terms of 12 successive 36 month renewal
periods.
As part
of the Securities Purchase Agreement, the Company, Wild Flavors and certain
shareholders of the Company owning approximately 34.12% of the Company's common
stock (the "Sunwin Shareholders") entered into a Stockholders Agreement dated
February 5, 2009 (the "Stockholders Agreement").  The Stockholders
Agreement provides that so long as Wild Flavors owns at least 4,000,000 shares
of the Common Stock, the parties will vote or cause their shares of the Common
Stock to be voted to elect two members of the Company's board of directors
designated by Wild Flavors and three members designated by the Sunwin
Shareholders.
The
descriptions of the terms and conditions of the Securities Purchase Agreement,
Operating Agreement, Distributorship Agreement and Stockholders Agreement set
forth herein do not purport to be complete and are qualified in their entirety
by reference to the full text of such documents attached hereto as exhibits and
incorporated herein by reference.
Item
      3.02
Recent
      Sales of Unregistered Securities.
Pursuant
to the Securities Purchase Agreement, Wild Flavors purchased 20,000,000 shares
(the "Shares") of the Company's Common Stock at a price of $.15 per share and
five year warrants to purchase 26,666,666 shares of the Common Stock with an
exercise price of $0.35 per share (the "Warrants").  Upon completion
of the sale of the Shares and other transactions agreed to in connection with
the Securities Purchase Agreement, Wild Flavors will own approximately 15.7% of
the issued and outstanding Common Stock of the Company. In addition, Sunwin USA
agreed to agreed to issue to Wild Flavors 4,500 membership units (the "Units")
(a 45% interest) in Sunwin USA in exchange for Wild Flavors' agreement to
provide the Services to Sunwin USA over a period of two years begining on
February 5, 2009.  The sale of the Shares, Warrants and Units is
hereinafter collectively referred to as the Wild Flavors
Offering.
- 1
-
The Wild
Flavors Offering was made in reliance on the exemption from registration
provided by Section 4(2) of the Securities Act of 1933. The sale of the Shares,
Warrants and Units (the "Sunwin Securities") to Wild Flavors, when completed,
will qualify for exemption under Section 4(2) of the Securities Act of 1933
since the sale by the Company and Sunwin USA did not involve a public offering.
Wild Flavors agreed not to resell the Sunwin Securities for a period of two
years after the February 5, 2009 closing date of the Wild Flavors
Offering.  In addition, Wild Flavors is a sophisticated investor and
had access to information normally provided in a prospectus regarding the
Company. The Wild Flavors Offering was not a "public offering" as defined in
Section 4(2) due to the insubstantial number of persons involved in the deal,
size of the offering, manner of the offering and number of shares offered. The
Company did not undertake an offering in which it sold a high number of shares
to a high number of investors. In addition, Wild Flavors had the necessary
investment intent as required by Section 4(2) since Wild Flavors agreed to allow
the Company to include a restrictive legend on any of the Sunwin Securities
acquired stating that such securities are restricted pursuant to Rule 144 of the
1933 Securities Act. These restrictions ensure that these securities would not
be immediately redistributed into the market and therefore not be part of a
"public offering." Based on an analysis of the above factors, the Company will
have met the requirements to qualify for exemption under Section 4(2) of the
Securities Act of 1933 for the Wild Flavors Offering.
The
Company paid fees in connection with the Securities Purchase Agreement of
$100,000 in cash and 1,000,000 shares of its Common Stock. In addition, the
Company paid legal fees to its counsel associated with the Securities Purchase
Agreement. After payment of these fees and costs associated with the Wild
Flavors Offering, the Company received net proceeds of approximately $2,885,000.
The net proceeds of this offering will be used for expansion of the Company's
Stevia production facilities in China and general corporate
purposes.
The
Securities Purchase Agreement gives Wild Flavors the right to receive notice of
and participate in the Company's proposed sale of its securities except for (i)
transactions involving strategic mergers, acquisitions; (ii) license and
partnering arrangements so long as such issuances are not for the purpose of
raising capital and which holders of such securities are not at any time granted
registration rights and issuances; (iii) grants pursuant to stock option plans
and employee stock purchase plans; and (iv) issuances as a result of the
exercise of existing warrants to purchase the Company's common
stock.
In
addition, the
Securities
Purchase Agreement also gives Wild Flavors, among other rights, a right of
first refusal with respect to subsequent offers, if any, by the Company for the
sale of its securities or debt obligations up until February 5, 2011. The right
of first refusal does not apply with respect to certain limited exceptions,
including strategic license agreements, mergers and similar acquisitions and
certain option programs.
The
descriptions of the terms and conditions of the Warrants set forth herein do not
purport to be complete and are qualified in their entirety by reference to the
full text of such document attached hereto as exhibits and incorporated herein
by reference.
Item
      7.01
Regulation
      FD Disclosure
On
February 11, 2009, Wild Flavors, Inc. and the Company issued a press release
announcing the business relationship contemplated in the Securities Purchase
Agreement and the agreements set forth in such agreement.  A copy of
the press release is attached hereto as Exhibit 99.1 and incorporated by
reference herein.
The
information in this item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liability of that section, and shall not be
incorporated by reference into any registration statement or other document
filed under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such
filing.
- 2
-
Item
      9.01
Financial
      Statements and Exhibits.
(d)
Exhibits
Exhibit
      No.
Description
4.1
Common
      Stock Purchase Warrant between Sunwin International Neutraceuticals, Inc.
      and Wild Flavors, Inc. dated February 5, 2009.
4.2
Stockholders
      Agreement dated February 5, 2009 Sunwin International Neutraceuticals,
      Inc., Laiwang Zhang, Dongdong Lin, Xingyuan Li, Junzhen Zhang, Xiangsheng
      Kong, Weidong Chai, Laiwang Zhang, Fanjun Wu and Wild Flavors,
      Inc.
10.1
Securities
      Purchase Agreement between Sunwin International Neutraceuticals, Inc. and
      Wild Flavors, Inc. dated February 5, 2009.
10.2
Form
      of Operating Agreement between Sunwin International Neutraceuticals, Inc.
      and Wild Flavors, Inc.
10.3
Distributorship
      Agreement dated February 5, 2009 among Sunwin International
      Neutraceuticals, Inc., Sunwin Stevia International Corp. and Wild Flavors,
      Inc.*
99.1
Joint
      Press Release of Wild Flavors, Inc. and Sunwin International
      Neutraceuticals, Inc. dated February 11, 2009 (furnished
      herewith).
*Portions
of this agreement have been omitted and marked with a
[_]
and separately filed
with the Securities and Exchange Commission with a request for confidential
treatment.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
Sunwin
      International Neutraceuticals, Inc.
Date:
      February 11, 2009
By:
/s/
      Dongdong Lin
Dongdong
      Lin, Chief Executive Officer
- 3
-